Covid-19 Seroprevalence Study

The Banco Sabadell Foundation is funding the first seroprevalence study of Covid-19 carried out by the Parc Taulí Hospital in Sabadell.

  • This is a groundbreaking study into the immune response among the hospital’s medical staff and a large group of patients, as well as in the target population in the city and region of Sabadell.
  • It aims to determine what proportion of the population has developed immunity to Covid-19 and to measure their antibody response in order to steer future efforts to protect people from the virus.